drugset / Trial / NCT05626712
Safety and Efficacy of CELZ-201 in Patients With Recent Onset Type 1 Diabetes
RandomizedParallel-groupOpen-labelTreatment
Summary
The brief purpose of this research study is to learn about the safety and efficacy of intra-arterial administration of CELZ-201 in patients with newly diagnosed Type 1 Diabetes Mellitus (T1D).
Timeline
- Start
- 2023-04-07
- Primary completion
- 2027-01-31
- Completion
- 2028-01-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CELZ-201 | Cell therapy | 1e+06 cells/kg | Other |